Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Sep 2;6(2):e001332. doi: 10.1136/rmdopen-2020-001332

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

Distribution between hospitalised and non-hospitalised patients.

Median age in group of hospitalised patients (HOSP) was 69 years and in non-hospitalised (NON-HOSP) was 52 years. More male patients were hospitalised (48%) compared to NON-HOSP (34%). HOSP were treated in 64% of the cases with GC, NON-HOSP in 34%. Thirty-three per cent of HOSP received bDMARDs compared to 48% of NON-HOSP. In HOSP, more comorbidities were observed (48%) compared to NON-HOSP (21%). bDMARD, biological disease-modifying antirheumatic drugs; Comorb., comorbidities; GC, glucocorticosteroids.